Cerevel Therapeutics Hldng I shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $31M | 721k | 42.40 |
| 2023-09-30 | $120M | 5.5M | 21.83 |
| 2023-06-30 | $166M | 5.2M | 31.79 |
| 2023-03-31 | $117M | 4.8M | 24.39 |
| 2022-12-31 | $152M | 4.8M | 31.54 |
| 2022-03-31 | $227M | 6.5M | 35.01 |
| 2021-12-31 | $195M | 6.0M | 32.42 |
| 2021-09-30 | $172M | 5.8M | 29.50 |
| 2021-06-30 | $85M | 3.3M | 25.62 |
| 2021-03-31 | $47M | 3.4M | 13.73 |
| 2020-12-31 | $54M | 3.4M | 15.92 |